What are peptide therapies? A clear educational guide to how they work and how they are used

Peptides have moved from specialized research labs into everyday conversations about metabolism, recovery, aging, and overall wellness. Yet the term “peptide therapy” is often used loosely, mixing FDA-approved medicines with investigational compounds and compounded products.

This guide explains what peptides actually are, how therapeutic peptides are used in medicine, the main categories of applications, important regulatory distinctions, and practical points to consider. The goal is straightforward: give you clear, evidence-based context so you can evaluate information and have more informed conversations with licensed healthcare providers.

What are peptides and what is peptide therapy?

Peptides are short chains of amino acids—the same building blocks that make up proteins. Most therapeutic peptides contain fewer than 50 amino acids (some definitions use a cutoff of 40). Because of their smaller size compared with full proteins, they can often bind to specific receptors with high precision and act as signaling molecules in the body.

“Peptide therapy” generally refers to the clinical or research use of synthetic or naturally occurring peptides to influence biological processes. These can include:

• Mimicking or modulating natural hormones
• Binding to specific receptors (for example, GLP-1 receptors)
• Supporting tissue repair or metabolic pathways in laboratory and clinical research settings

Peptides have been part of medicine for decades. Insulin, one of the earliest peptide drugs, was introduced in the 1920s. Today more than 80 peptide-based drugs have received regulatory approval worldwide for a range of conditions.

How do therapeutic peptides work?

Most therapeutic peptides act by binding to specific cell-surface receptors or by influencing signaling pathways. Common mechanisms include:

• Stimulating or inhibiting hormone release
• Slowing gastric emptying and reducing appetite (GLP-1 receptor agonists)
• Supporting insulin secretion in a glucose-dependent manner
• Interacting with pathways involved in tissue repair or inflammation (studied in research settings)

Because they are often highly selective, peptides can produce targeted effects with fewer off-target interactions than some small-molecule drugs. However, they are typically broken down by enzymes in the digestive system, which is why many are administered by injection rather than orally (though oral formulations of some peptides, such as certain forms of semaglutide, now exist).

Common categories and applications of peptides

Therapeutic peptides are used across several areas of medicine and research:

• Metabolic and endocrine applications
• GLP-1 receptor agonists (semaglutide, liraglutide) and dual agonists (tirzepatide) are FDA-approved for type 2 diabetes and chronic weight management.
• Insulin and certain other peptide hormones remain foundational treatments for diabetes and related conditions.

2. Growth hormone–related pathways

• Some peptides (for example, sermorelin historically) have been studied or used in specific diagnostic or replacement contexts under medical supervision.

3. Tissue repair and regenerative research

• Compounds such as BPC-157 and TB-500 appear frequently in research literature and wellness discussions. Human clinical evidence for many of these remains limited compared with approved drugs.

4. Other approved or investigational uses

• Peptides are also used in areas such as rare genetic disorders, certain cancers, infectious disease, and diagnostic imaging. Newer approvals continue to expand the list of regulated peptide medicines.

It is important to distinguish FDA-approved peptide drugs (which have undergone rigorous clinical testing and regulatory review) from compounded or investigational peptides (which have not received the same level of pre-market evaluation for safety, effectiveness, and quality).

How are peptide therapies typically used?

• Administration: Many therapeutic peptides are given by subcutaneous injection. Some are available in oral, nasal, or other formulations depending on the specific molecule and approved product.
• Prescription status: FDA-approved peptide drugs require a prescription from a licensed healthcare provider. Compounded versions, when legally prepared, also require a patient-specific prescription in most cases.
• Monitoring: Clinical use of approved peptides usually involves baseline evaluation, ongoing monitoring for side effects (commonly gastrointestinal with the incretin class), and assessment of response.
• Research vs. clinical use: Many peptides sold online are labeled “for research purposes only.” Using research-grade materials for human administration falls outside regulated medical practice and carries significant safety and legal considerations.

Regulatory context for peptides in 2026

The regulatory landscape for peptides continues to evolve. Key points include:

• FDA-approved peptide drugs have completed clinical trials and manufacturing quality reviews.
• Compounded peptides are prepared by licensed pharmacies under specific conditions (503A or 503B frameworks) and are not FDA-approved. The FDA has issued warnings about misleading marketing of compounded products.
• Certain peptides remain restricted or under review for compounding eligibility. Recent advisory committee discussions have examined several research peptides for potential inclusion on bulk substance lists, but final regulatory status can change.
• Investigational peptides (such as retatrutide as of mid-2026) are available only through formal clinical trials until approved.

Transparency about a product’s regulatory status is one of the most important factors when evaluating any information or option.

Key considerations for informed decision-making

When exploring information about peptides, helpful questions include:

• Is this an FDA-approved drug or a compounded/investigational compound?
• What primary clinical trial evidence supports its use for a specific indication?
• What are the known risks, side effects, and monitoring requirements?
• Who is responsible for the medical evaluation and prescription (if applicable)?
• Is the product coming from a licensed pharmacy channel?

Reliable educational resources cite peer-reviewed studies and official regulatory statements rather than promotional claims.

Frequently asked questions about peptides

Learn more about peptides with clear, unbiased education

SFS Wellness serves as a trusted resource hub for information about the latest peptide research and related wellness topics. We provide straightforward educational content so you can better understand options and decide your next steps with confidence. No account, intake form, or personal information is required to explore our resources.

If you would like clearer context on available approaches or the typical process involved, start with our free non-medical information consultation (opens an external Calendly scheduling page) or browse the educational materials on the SFS Wellness site. Education first—so any conversation you later have with a licensed clinician is more informed.